Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286974637> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4286974637 abstract "Neurocysticercosis (NCC) is a significant problem in India and other developing countries; however, several aspects of this disease have no clear, practical guidelines. There is a need for pragmatic guidelines, summarizing the available evidence, and filling in the gaps in evidence with expert advice to manage children with neurocysticercosis.An expert group (16 members) and a writing group (8 members) was constituted, consisting of members with varied expertise. It included pediatric neurologists (18), neurologist (1), Neuroradiologists (4), and a parasitologist (1). The writing group divided the six topics and reviewed the literature on the topics individually to determine the clinical questions for which no clear guidance was available from the literature. The experts were then contacted and opinions were obtained online. The Delphi consensus method was adopted to arrive at a general consensus regarding various questions, with both the experts and the writing group members contributing. The final guidelines were then drafted by the writing group.Diagnosis of NCC should be based on clinical history and neuroimaging. Contrast-enhanced magnetic resonance imaging of the brain is the modality of choice. For single enhancing lesion, albendazole therapy for 10-14 days is recommended, and it should be combined with praziquantel for 10-14 days for more than one ring-enhancing lesions. For persistent lesion, the same dose and duration of albendazole or concurrent administration of albendazole and praziquantel should be given. Pulse intravenous steroids should be used to reduce the acute symptomatic edema in children with cysticercal encephalitis. Carbamazepine or oxcarbazepine are best suited for seizure prophylaxis for those who present with seizures; phenytoin and levetiracetam are the other alternatives. In the case of NCC presenting with symptoms other than seizures, there appears to be no role for routine anti-seizure medication prophylaxis. For a single ring-enhancing lesion, six months of anti-seizure medication is sufficient if the lesion resolves on follow-up. Those with persistent lesions, calcification, or multiple lesions, require a longer treatment duration of at least 24 months." @default.
- W4286974637 created "2022-07-25" @default.
- W4286974637 creator A5000955664 @default.
- W4286974637 creator A5007360495 @default.
- W4286974637 creator A5013830001 @default.
- W4286974637 creator A5020897132 @default.
- W4286974637 creator A5034291730 @default.
- W4286974637 creator A5037524818 @default.
- W4286974637 creator A5054660624 @default.
- W4286974637 creator A5080867198 @default.
- W4286974637 date "2021-09-15" @default.
- W4286974637 modified "2023-09-29" @default.
- W4286974637 title "Management of Neurocysticercosis in Children: Association of Child Neurology Consensus Guidelines." @default.
- W4286974637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34338221" @default.
- W4286974637 hasPublicationYear "2021" @default.
- W4286974637 type Work @default.
- W4286974637 citedByCount "1" @default.
- W4286974637 countsByYear W42869746372022 @default.
- W4286974637 crossrefType "journal-article" @default.
- W4286974637 hasAuthorship W4286974637A5000955664 @default.
- W4286974637 hasAuthorship W4286974637A5007360495 @default.
- W4286974637 hasAuthorship W4286974637A5013830001 @default.
- W4286974637 hasAuthorship W4286974637A5020897132 @default.
- W4286974637 hasAuthorship W4286974637A5034291730 @default.
- W4286974637 hasAuthorship W4286974637A5037524818 @default.
- W4286974637 hasAuthorship W4286974637A5054660624 @default.
- W4286974637 hasAuthorship W4286974637A5080867198 @default.
- W4286974637 hasConcept C118552586 @default.
- W4286974637 hasConcept C141071460 @default.
- W4286974637 hasConcept C142724271 @default.
- W4286974637 hasConcept C16568411 @default.
- W4286974637 hasConcept C187212893 @default.
- W4286974637 hasConcept C2777065887 @default.
- W4286974637 hasConcept C2778056992 @default.
- W4286974637 hasConcept C2778186239 @default.
- W4286974637 hasConcept C2779253243 @default.
- W4286974637 hasConcept C2780449708 @default.
- W4286974637 hasConcept C2781176495 @default.
- W4286974637 hasConcept C2911202600 @default.
- W4286974637 hasConcept C58693492 @default.
- W4286974637 hasConcept C71924100 @default.
- W4286974637 hasConceptScore W4286974637C118552586 @default.
- W4286974637 hasConceptScore W4286974637C141071460 @default.
- W4286974637 hasConceptScore W4286974637C142724271 @default.
- W4286974637 hasConceptScore W4286974637C16568411 @default.
- W4286974637 hasConceptScore W4286974637C187212893 @default.
- W4286974637 hasConceptScore W4286974637C2777065887 @default.
- W4286974637 hasConceptScore W4286974637C2778056992 @default.
- W4286974637 hasConceptScore W4286974637C2778186239 @default.
- W4286974637 hasConceptScore W4286974637C2779253243 @default.
- W4286974637 hasConceptScore W4286974637C2780449708 @default.
- W4286974637 hasConceptScore W4286974637C2781176495 @default.
- W4286974637 hasConceptScore W4286974637C2911202600 @default.
- W4286974637 hasConceptScore W4286974637C58693492 @default.
- W4286974637 hasConceptScore W4286974637C71924100 @default.
- W4286974637 hasLocation W42869746371 @default.
- W4286974637 hasOpenAccess W4286974637 @default.
- W4286974637 hasPrimaryLocation W42869746371 @default.
- W4286974637 hasRelatedWork W10149345 @default.
- W4286974637 hasRelatedWork W10983366 @default.
- W4286974637 hasRelatedWork W11783385 @default.
- W4286974637 hasRelatedWork W13591847 @default.
- W4286974637 hasRelatedWork W1765519 @default.
- W4286974637 hasRelatedWork W17709204 @default.
- W4286974637 hasRelatedWork W19899367 @default.
- W4286974637 hasRelatedWork W22251877 @default.
- W4286974637 hasRelatedWork W3042061 @default.
- W4286974637 hasRelatedWork W4596249 @default.
- W4286974637 isParatext "false" @default.
- W4286974637 isRetracted "false" @default.
- W4286974637 workType "article" @default.